Expertise in
2
conditions

Lingwei X. Wang

Shenzhen, CN 
Expertise in
2
conditions
Shenzhen, CN 

Overview

Lingwei Wang practices practicing medicine in Shenzhen, China.

Wang is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Pulmonary Actinomycosis, Psittacosis, Chronic Obstructive Pulmonary Disease (COPD), and Asthma.

They are actively involved in clinical research, co-authoring 62 peer reviewed articles and participating in 1 clinical trial.

Locations

Shenzhen, China
Other Locations
Guangzhou, 510632, China
Chengdu, 610041, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Device, Drug
Study Drugs: FF/VI, FF/UMEC/VI
Study Phase: Phase 3

62 Total Publications

Low-dose theophylline in mild to moderate Chronic Obstructive Pulmonary Disease: A randomized clinical trial in China.
Low-dose theophylline in mild to moderate Chronic Obstructive Pulmonary Disease: A randomized clinical trial in China.
Journal: Pulmonology
Published: April 07, 2026

Frequently Asked Questions about Lingwei X. Wang

Is Lingwei X. Wang a top-rated expert for Pulmonary Actinomycosis?

MediFind is an objective health platform that identifies experts based on real-world data. Lingwei X. Wang is classified as an Advanced expert for Pulmonary Actinomycosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lingwei X. Wang participate in research or clinical trials?

Yes. Lingwei X. Wang has published 62 articles and abstracts on conditions like Pulmonary Actinomycosis. You can view a list of Lingwei X. Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile